VentureSouth is a venture capital firm based in Greenville, South Carolina, specializing in startup and early-stage investments. The firm focuses primarily on manufacturing, logistics, and healthcare sectors, targeting opportunities in the Southeastern United States, particularly the Carolinas and surrounding areas. Since its founding, VentureSouth has developed a network of over 550 investors through various angel investment groups, making it one of the largest organizations of its kind in the country. The firm typically invests between $0.25 million and $2 million for a preferred equity stake of 15% to 35%, aiming for companies that can potentially deliver a 50% annualized rate of return within a 3-5 year timeframe. VentureSouth does not engage in common equity or debt investments, and it rarely invests in convertible debt.
Kiyatec, LLC is a biotechnology company based in Greenville, South Carolina, specializing in the development of advanced 3D cell-based assays for preclinical drug discovery and clinical therapy applications. The company utilizes patients' own living tumor cells to create functional 3D models that facilitate testing of various cancer therapies, enhancing the predictive accuracy of drug responses. Its innovative 3DKUBE technology platform supports in situ imaging and accommodates different scaffold materials, allowing for the modeling of complex human biology through segregated cell co-culture. Kiyatec's services include drug response profiling, toxicity evaluation, and the development of cell-based models for testing small molecules, biologic drugs, and immunotherapies. The company also engages in contract research projects and collaborates with the National Cancer Institute to advance research on cancer types such as breast cancer, glioblastoma, and lung cancer. Founded in 2005, Kiyatec aims to assist medical practitioners in identifying effective treatments for cancer patients by providing insights prior to clinical trials.
Zylö Therapeutics
Series B in 2022
Zylo Therapeutics, Inc. is a life sciences company based in Greenville, South Carolina, specializing in a sustained-release drug delivery system. Founded in 2017, the company has developed a delivery mechanism that employs patented hydrogel-derived nanoparticles, known as Nanopods™, to facilitate the topical administration of difficult-to-deliver therapeutic agents, including nitric oxide. This innovative system enhances drug delivery capabilities and is designed to improve the treatment of various conditions such as lupus, hair loss, joint pain, and burns. By utilizing engineered amorphous silica particles, Zylo Therapeutics aims to provide a controlled and sustained release of medications, thereby enhancing product performance and patient outcomes.
Case Status
Series A in 2022
Case Status, Inc. is a company that specializes in developing a cloud-based client engagement tool tailored for the legal services industry. Founded in 2017 by Andrew Seavers and Lauren Sturdivant, the company is headquartered in Birmingham, Alabama, with an additional office in Charleston, South Carolina. The platform aims to enhance lawyer-client communications by addressing common challenges faced by legal professionals. It offers features that allow law firms to track and measure client satisfaction, send timely updates, and facilitate effective communication with clients. By providing real-time visibility of cases and automating routine interactions, Case Status helps law firms reduce the need for frequent meetings and improve overall client relationships.
Kiyatec
Venture Round in 2021
Kiyatec, LLC is a biotechnology company based in Greenville, South Carolina, specializing in the development of advanced 3D cell-based assays for preclinical drug discovery and clinical therapy applications. The company utilizes patients' own living tumor cells to create functional 3D models that facilitate testing of various cancer therapies, enhancing the predictive accuracy of drug responses. Its innovative 3DKUBE technology platform supports in situ imaging and accommodates different scaffold materials, allowing for the modeling of complex human biology through segregated cell co-culture. Kiyatec's services include drug response profiling, toxicity evaluation, and the development of cell-based models for testing small molecules, biologic drugs, and immunotherapies. The company also engages in contract research projects and collaborates with the National Cancer Institute to advance research on cancer types such as breast cancer, glioblastoma, and lung cancer. Founded in 2005, Kiyatec aims to assist medical practitioners in identifying effective treatments for cancer patients by providing insights prior to clinical trials.
Zylö Therapeutics
Series A in 2019
Zylo Therapeutics, Inc. is a life sciences company based in Greenville, South Carolina, specializing in a sustained-release drug delivery system. Founded in 2017, the company has developed a delivery mechanism that employs patented hydrogel-derived nanoparticles, known as Nanopods™, to facilitate the topical administration of difficult-to-deliver therapeutic agents, including nitric oxide. This innovative system enhances drug delivery capabilities and is designed to improve the treatment of various conditions such as lupus, hair loss, joint pain, and burns. By utilizing engineered amorphous silica particles, Zylo Therapeutics aims to provide a controlled and sustained release of medications, thereby enhancing product performance and patient outcomes.
Treis Blockchain
Convertible Note in 2019
Treis Blockchain, providing distributed blockchain verification services and solutions consulting. The company processes digital currency and other blockchain transactions. It data mines cryptocurrency, preventing cyberattacks in the financial and retail industries. Michael Bolick established the company in Greer, South Carolina in 2017.
Zylö Therapeutics
Seed Round in 2019
Zylo Therapeutics, Inc. is a life sciences company based in Greenville, South Carolina, specializing in a sustained-release drug delivery system. Founded in 2017, the company has developed a delivery mechanism that employs patented hydrogel-derived nanoparticles, known as Nanopods™, to facilitate the topical administration of difficult-to-deliver therapeutic agents, including nitric oxide. This innovative system enhances drug delivery capabilities and is designed to improve the treatment of various conditions such as lupus, hair loss, joint pain, and burns. By utilizing engineered amorphous silica particles, Zylo Therapeutics aims to provide a controlled and sustained release of medications, thereby enhancing product performance and patient outcomes.
Kiyatec
Series B in 2019
Kiyatec, LLC is a biotechnology company based in Greenville, South Carolina, specializing in the development of advanced 3D cell-based assays for preclinical drug discovery and clinical therapy applications. The company utilizes patients' own living tumor cells to create functional 3D models that facilitate testing of various cancer therapies, enhancing the predictive accuracy of drug responses. Its innovative 3DKUBE technology platform supports in situ imaging and accommodates different scaffold materials, allowing for the modeling of complex human biology through segregated cell co-culture. Kiyatec's services include drug response profiling, toxicity evaluation, and the development of cell-based models for testing small molecules, biologic drugs, and immunotherapies. The company also engages in contract research projects and collaborates with the National Cancer Institute to advance research on cancer types such as breast cancer, glioblastoma, and lung cancer. Founded in 2005, Kiyatec aims to assist medical practitioners in identifying effective treatments for cancer patients by providing insights prior to clinical trials.
Sharpen
Seed Round in 2018
Resiliency Technologies, Inc. operates Sharpen, a cloud-based technology and analytics platform focused on mental health and wellness. Headquartered in Spartanburg, South Carolina, the platform tracks individual and group behaviors to generate targeted recommendations through real-time analytics. Sharpen provides educational resources aimed at addressing the root causes of mental health issues such as stress, depression, and obesity. It facilitates connections among researchers, educators, and corporations to deliver evidence-based interventions, thereby supporting the prevention, early intervention, and treatment of mental health and substance use disorders. Founded in 2014, Resiliency Technologies brings over a century of expertise in the medical technology field to its mission of promoting mental well-being.
Proterra
Series G in 2018
Proterra Inc. is a manufacturer of zero-emission electric buses, primarily focused on providing sustainable transportation solutions for public and commercial transit. Founded in 2004 and headquartered in Burlingame, California, with additional offices in Greenville, South Carolina, and City of Industry, California, Proterra designs its products, including 35-foot and 40-foot electric buses, to meet the diverse needs of urban and regional transit routes. The company's Catalyst platform is noted for its modularity, allowing it to adapt to various operational demands while delivering high energy efficiency. Proterra also offers a broad range of services, including vehicle electrification solutions, fleet planning, charging infrastructure, and comprehensive vehicle maintenance programs. By facilitating the transition away from fossil fuels, Proterra aims to enhance environmental quality and reduce operational costs for fleet operators, contributing to significant reductions in greenhouse gas emissions.
Atlas Organics
Series A in 2018
Atlas Organics Inc. is a company that specializes in organics recycling, focusing on the collection and recycling of food and yard waste. Founded in 2013 and headquartered in Spartanburg, South Carolina, Atlas Organics operates in regions including San Antonio, Texas, and various areas in South Carolina, North Carolina, and Tennessee. The company partners with municipalities to collect food waste from various sources such as grocery stores, hospitals, and schools, thereby advancing sustainability initiatives. Atlas Organics transforms this waste into organic compost products suitable for agricultural, landscaping, and home gardening applications. By promoting the "table to farm" movement, Atlas Organics helps its clients achieve their sustainability goals while diverting compostable materials from landfills. The company's composting facilities produce valuable nutrients that enhance soil health, supporting both environmental and agricultural practices.
CharlestonPharma
Seed Round in 2018
CharlestonPharma, LLC is dedicated to developing innovative therapeutic products aimed at cancer patients and healthcare providers. The company specializes in creating fully human monoclonal antibodies that target nucleolin, a cell surface receptor associated with various cancers. With an exclusive worldwide license from the Medical University of South Carolina for eight specific antibodies and the technology to produce additional antibodies, CharlestonPharma focuses on demonstrating the preclinical efficacy and safety of its anti-nucleolin antibodies. Laboratory studies indicate that these antibodies can selectively kill cancer cells while sparing normal cells, minimizing toxicity. Additionally, the company is working on diagnostic tests that utilize cell surface nucleolin to aid in the prognosis and diagnosis of malignant diseases. CharlestonPharma operates from the Charleston Innovation Center, where its research aims to identify the most promising antibodies for future in vivo studies. The company was incorporated in 2010 and is based in Charleston, South Carolina.
Kiyatec
Convertible Note in 2017
Kiyatec, LLC is a biotechnology company based in Greenville, South Carolina, specializing in the development of advanced 3D cell-based assays for preclinical drug discovery and clinical therapy applications. The company utilizes patients' own living tumor cells to create functional 3D models that facilitate testing of various cancer therapies, enhancing the predictive accuracy of drug responses. Its innovative 3DKUBE technology platform supports in situ imaging and accommodates different scaffold materials, allowing for the modeling of complex human biology through segregated cell co-culture. Kiyatec's services include drug response profiling, toxicity evaluation, and the development of cell-based models for testing small molecules, biologic drugs, and immunotherapies. The company also engages in contract research projects and collaborates with the National Cancer Institute to advance research on cancer types such as breast cancer, glioblastoma, and lung cancer. Founded in 2005, Kiyatec aims to assist medical practitioners in identifying effective treatments for cancer patients by providing insights prior to clinical trials.
PharmRight
Convertible Note in 2017
PharmRight Corporation, founded in 2013 and based in Charleston, South Carolina, focuses on designing and developing medical devices aimed at enhancing medication adherence at home. The company's flagship product, Livi, is an automated pill dispenser that helps users manage their medication schedules independently. Livi is designed to support both patients and their caregivers, simplifying the process of handling multiple medications while offering crucial assistance to caregivers. In addition to its innovative devices, PharmRight also provides a range of prescribed and non-prescribed medicines and other drugs, reinforcing its commitment to improving health outcomes through better medication management.
Proterra
Series F in 2017
Proterra Inc. is a manufacturer of zero-emission electric buses, primarily focused on providing sustainable transportation solutions for public and commercial transit. Founded in 2004 and headquartered in Burlingame, California, with additional offices in Greenville, South Carolina, and City of Industry, California, Proterra designs its products, including 35-foot and 40-foot electric buses, to meet the diverse needs of urban and regional transit routes. The company's Catalyst platform is noted for its modularity, allowing it to adapt to various operational demands while delivering high energy efficiency. Proterra also offers a broad range of services, including vehicle electrification solutions, fleet planning, charging infrastructure, and comprehensive vehicle maintenance programs. By facilitating the transition away from fossil fuels, Proterra aims to enhance environmental quality and reduce operational costs for fleet operators, contributing to significant reductions in greenhouse gas emissions.
CharlestonPharma
Seed Round in 2017
CharlestonPharma, LLC is dedicated to developing innovative therapeutic products aimed at cancer patients and healthcare providers. The company specializes in creating fully human monoclonal antibodies that target nucleolin, a cell surface receptor associated with various cancers. With an exclusive worldwide license from the Medical University of South Carolina for eight specific antibodies and the technology to produce additional antibodies, CharlestonPharma focuses on demonstrating the preclinical efficacy and safety of its anti-nucleolin antibodies. Laboratory studies indicate that these antibodies can selectively kill cancer cells while sparing normal cells, minimizing toxicity. Additionally, the company is working on diagnostic tests that utilize cell surface nucleolin to aid in the prognosis and diagnosis of malignant diseases. CharlestonPharma operates from the Charleston Innovation Center, where its research aims to identify the most promising antibodies for future in vivo studies. The company was incorporated in 2010 and is based in Charleston, South Carolina.
Proterra
Series E in 2017
Proterra Inc. is a manufacturer of zero-emission electric buses, primarily focused on providing sustainable transportation solutions for public and commercial transit. Founded in 2004 and headquartered in Burlingame, California, with additional offices in Greenville, South Carolina, and City of Industry, California, Proterra designs its products, including 35-foot and 40-foot electric buses, to meet the diverse needs of urban and regional transit routes. The company's Catalyst platform is noted for its modularity, allowing it to adapt to various operational demands while delivering high energy efficiency. Proterra also offers a broad range of services, including vehicle electrification solutions, fleet planning, charging infrastructure, and comprehensive vehicle maintenance programs. By facilitating the transition away from fossil fuels, Proterra aims to enhance environmental quality and reduce operational costs for fleet operators, contributing to significant reductions in greenhouse gas emissions.
Atlas Organics
Convertible Note in 2017
Atlas Organics Inc. is a company that specializes in organics recycling, focusing on the collection and recycling of food and yard waste. Founded in 2013 and headquartered in Spartanburg, South Carolina, Atlas Organics operates in regions including San Antonio, Texas, and various areas in South Carolina, North Carolina, and Tennessee. The company partners with municipalities to collect food waste from various sources such as grocery stores, hospitals, and schools, thereby advancing sustainability initiatives. Atlas Organics transforms this waste into organic compost products suitable for agricultural, landscaping, and home gardening applications. By promoting the "table to farm" movement, Atlas Organics helps its clients achieve their sustainability goals while diverting compostable materials from landfills. The company's composting facilities produce valuable nutrients that enhance soil health, supporting both environmental and agricultural practices.
PharmRight
Convertible Note in 2016
PharmRight Corporation, founded in 2013 and based in Charleston, South Carolina, focuses on designing and developing medical devices aimed at enhancing medication adherence at home. The company's flagship product, Livi, is an automated pill dispenser that helps users manage their medication schedules independently. Livi is designed to support both patients and their caregivers, simplifying the process of handling multiple medications while offering crucial assistance to caregivers. In addition to its innovative devices, PharmRight also provides a range of prescribed and non-prescribed medicines and other drugs, reinforcing its commitment to improving health outcomes through better medication management.
PharmRight
Convertible Note in 2016
PharmRight Corporation, founded in 2013 and based in Charleston, South Carolina, focuses on designing and developing medical devices aimed at enhancing medication adherence at home. The company's flagship product, Livi, is an automated pill dispenser that helps users manage their medication schedules independently. Livi is designed to support both patients and their caregivers, simplifying the process of handling multiple medications while offering crucial assistance to caregivers. In addition to its innovative devices, PharmRight also provides a range of prescribed and non-prescribed medicines and other drugs, reinforcing its commitment to improving health outcomes through better medication management.
Kiyatec
Series B in 2015
Kiyatec, LLC is a biotechnology company based in Greenville, South Carolina, specializing in the development of advanced 3D cell-based assays for preclinical drug discovery and clinical therapy applications. The company utilizes patients' own living tumor cells to create functional 3D models that facilitate testing of various cancer therapies, enhancing the predictive accuracy of drug responses. Its innovative 3DKUBE technology platform supports in situ imaging and accommodates different scaffold materials, allowing for the modeling of complex human biology through segregated cell co-culture. Kiyatec's services include drug response profiling, toxicity evaluation, and the development of cell-based models for testing small molecules, biologic drugs, and immunotherapies. The company also engages in contract research projects and collaborates with the National Cancer Institute to advance research on cancer types such as breast cancer, glioblastoma, and lung cancer. Founded in 2005, Kiyatec aims to assist medical practitioners in identifying effective treatments for cancer patients by providing insights prior to clinical trials.
Servosity
Convertible Note in 2015
Servosity, Inc. specializes in IT backup and disaster recovery services tailored for managed service providers (MSPs) and IT resellers. Founded in 2005 and based in Greenville, South Carolina, the company offers a range of services including VMware and Hyper-V disaster recovery, along with support for various officially supported platforms. Servosity provides a web portal and open API for easier integration, robust infrastructure and security features, and around-the-clock customer support. Its technology is designed to protect data across virtual, physical, and cloud environments, ensuring that both on-premise and off-site data can be quickly restored, thereby minimizing downtime during disaster recovery situations.
Atlas Organics
Seed Round in 2015
Atlas Organics Inc. is a company that specializes in organics recycling, focusing on the collection and recycling of food and yard waste. Founded in 2013 and headquartered in Spartanburg, South Carolina, Atlas Organics operates in regions including San Antonio, Texas, and various areas in South Carolina, North Carolina, and Tennessee. The company partners with municipalities to collect food waste from various sources such as grocery stores, hospitals, and schools, thereby advancing sustainability initiatives. Atlas Organics transforms this waste into organic compost products suitable for agricultural, landscaping, and home gardening applications. By promoting the "table to farm" movement, Atlas Organics helps its clients achieve their sustainability goals while diverting compostable materials from landfills. The company's composting facilities produce valuable nutrients that enhance soil health, supporting both environmental and agricultural practices.
GrowJourney
Convertible Note in 2015
GrowJourney, LLC, founded in 2014 and based in Greenville, South Carolina, specializes in selling organic seeds online and providing educational resources for organic gardening. The company aims to make organic gardening straightforward and accessible to all by offering a selection of seasonal certified organic heirloom seeds. In addition to their products, GrowJourney supplies valuable gardening tips and instructions through their online platform, helping gardeners plan and maintain their gardens effectively. By promoting organic gardening practices, GrowJourney supports individuals in saving money on retail organic products and achieving a return on their gardening investments.
PharmRight
Series A in 2015
PharmRight Corporation, founded in 2013 and based in Charleston, South Carolina, focuses on designing and developing medical devices aimed at enhancing medication adherence at home. The company's flagship product, Livi, is an automated pill dispenser that helps users manage their medication schedules independently. Livi is designed to support both patients and their caregivers, simplifying the process of handling multiple medications while offering crucial assistance to caregivers. In addition to its innovative devices, PharmRight also provides a range of prescribed and non-prescribed medicines and other drugs, reinforcing its commitment to improving health outcomes through better medication management.
CharlestonPharma
Seed Round in 2015
CharlestonPharma, LLC is dedicated to developing innovative therapeutic products aimed at cancer patients and healthcare providers. The company specializes in creating fully human monoclonal antibodies that target nucleolin, a cell surface receptor associated with various cancers. With an exclusive worldwide license from the Medical University of South Carolina for eight specific antibodies and the technology to produce additional antibodies, CharlestonPharma focuses on demonstrating the preclinical efficacy and safety of its anti-nucleolin antibodies. Laboratory studies indicate that these antibodies can selectively kill cancer cells while sparing normal cells, minimizing toxicity. Additionally, the company is working on diagnostic tests that utilize cell surface nucleolin to aid in the prognosis and diagnosis of malignant diseases. CharlestonPharma operates from the Charleston Innovation Center, where its research aims to identify the most promising antibodies for future in vivo studies. The company was incorporated in 2010 and is based in Charleston, South Carolina.
The Iron Yard
Convertible Note in 2014
The Iron Yard LLC is an accelerator based in Greenville, South Carolina, with an additional office in Las Vegas, Nevada. Founded in 2011, the company specializes in seed and startup investments in technology sectors, focusing on software and software/hardware combinations. Its investment areas include healthcare, medical devices, biotech, energy, environment, wellness apps, mobile technology, and enterprise software. The Iron Yard operates three distinct programs: edu tech, open tech, and green tech. Each program lasts three months and accommodates up to ten companies. The firm provides an initial investment of $20,000 during the program and typically selects at least two companies for further funding up to $1 million, taking a six percent equity stake. While the firm prefers teams of two or more founders, it may occasionally consider solo founders. The Iron Yard is dedicated to nurturing talented developers and startups, equipping them with essential skills for long-term success in the technology industry.
Kiyatec
Convertible Note in 2014
Kiyatec, LLC is a biotechnology company based in Greenville, South Carolina, specializing in the development of advanced 3D cell-based assays for preclinical drug discovery and clinical therapy applications. The company utilizes patients' own living tumor cells to create functional 3D models that facilitate testing of various cancer therapies, enhancing the predictive accuracy of drug responses. Its innovative 3DKUBE technology platform supports in situ imaging and accommodates different scaffold materials, allowing for the modeling of complex human biology through segregated cell co-culture. Kiyatec's services include drug response profiling, toxicity evaluation, and the development of cell-based models for testing small molecules, biologic drugs, and immunotherapies. The company also engages in contract research projects and collaborates with the National Cancer Institute to advance research on cancer types such as breast cancer, glioblastoma, and lung cancer. Founded in 2005, Kiyatec aims to assist medical practitioners in identifying effective treatments for cancer patients by providing insights prior to clinical trials.
Zipit Wireless
Convertible Note in 2014
Zipit Wireless, Inc. is a technology company based in Greenville, South Carolina, specializing in critical messaging and Internet of Things (IoT) solutions. Founded in 2007, the company provides instant communication services designed for critical situations, catering to various sectors such as healthcare, education, government, and hospitality. Its Enterprise Critical Messaging Solution enables two-way communication for organizations, enhancing operational efficiency during emergencies. Additionally, Zipit offers cloud-based software and cellular services that support the management of connected devices, including wireless trail cameras and medication adherence devices. The company's subscription platform facilitates cellular activation and provides comprehensive business reports, allowing enterprises to streamline their operations and manage mobile workers effectively. Zipit Wireless markets its innovative software and services on a global scale, helping clients navigate the complexities of IoT connectivity.
PharmRight
Seed Round in 2014
PharmRight Corporation, founded in 2013 and based in Charleston, South Carolina, focuses on designing and developing medical devices aimed at enhancing medication adherence at home. The company's flagship product, Livi, is an automated pill dispenser that helps users manage their medication schedules independently. Livi is designed to support both patients and their caregivers, simplifying the process of handling multiple medications while offering crucial assistance to caregivers. In addition to its innovative devices, PharmRight also provides a range of prescribed and non-prescribed medicines and other drugs, reinforcing its commitment to improving health outcomes through better medication management.
Kiyatec
Series A in 2014
Kiyatec, LLC is a biotechnology company based in Greenville, South Carolina, specializing in the development of advanced 3D cell-based assays for preclinical drug discovery and clinical therapy applications. The company utilizes patients' own living tumor cells to create functional 3D models that facilitate testing of various cancer therapies, enhancing the predictive accuracy of drug responses. Its innovative 3DKUBE technology platform supports in situ imaging and accommodates different scaffold materials, allowing for the modeling of complex human biology through segregated cell co-culture. Kiyatec's services include drug response profiling, toxicity evaluation, and the development of cell-based models for testing small molecules, biologic drugs, and immunotherapies. The company also engages in contract research projects and collaborates with the National Cancer Institute to advance research on cancer types such as breast cancer, glioblastoma, and lung cancer. Founded in 2005, Kiyatec aims to assist medical practitioners in identifying effective treatments for cancer patients by providing insights prior to clinical trials.
The Iron Yard
Series A in 2014
The Iron Yard LLC is an accelerator based in Greenville, South Carolina, with an additional office in Las Vegas, Nevada. Founded in 2011, the company specializes in seed and startup investments in technology sectors, focusing on software and software/hardware combinations. Its investment areas include healthcare, medical devices, biotech, energy, environment, wellness apps, mobile technology, and enterprise software. The Iron Yard operates three distinct programs: edu tech, open tech, and green tech. Each program lasts three months and accommodates up to ten companies. The firm provides an initial investment of $20,000 during the program and typically selects at least two companies for further funding up to $1 million, taking a six percent equity stake. While the firm prefers teams of two or more founders, it may occasionally consider solo founders. The Iron Yard is dedicated to nurturing talented developers and startups, equipping them with essential skills for long-term success in the technology industry.
Proterra
Series C in 2013
Proterra Inc. is a manufacturer of zero-emission electric buses, primarily focused on providing sustainable transportation solutions for public and commercial transit. Founded in 2004 and headquartered in Burlingame, California, with additional offices in Greenville, South Carolina, and City of Industry, California, Proterra designs its products, including 35-foot and 40-foot electric buses, to meet the diverse needs of urban and regional transit routes. The company's Catalyst platform is noted for its modularity, allowing it to adapt to various operational demands while delivering high energy efficiency. Proterra also offers a broad range of services, including vehicle electrification solutions, fleet planning, charging infrastructure, and comprehensive vehicle maintenance programs. By facilitating the transition away from fossil fuels, Proterra aims to enhance environmental quality and reduce operational costs for fleet operators, contributing to significant reductions in greenhouse gas emissions.
Kiyatec
Convertible Note in 2013
Kiyatec, LLC is a biotechnology company based in Greenville, South Carolina, specializing in the development of advanced 3D cell-based assays for preclinical drug discovery and clinical therapy applications. The company utilizes patients' own living tumor cells to create functional 3D models that facilitate testing of various cancer therapies, enhancing the predictive accuracy of drug responses. Its innovative 3DKUBE technology platform supports in situ imaging and accommodates different scaffold materials, allowing for the modeling of complex human biology through segregated cell co-culture. Kiyatec's services include drug response profiling, toxicity evaluation, and the development of cell-based models for testing small molecules, biologic drugs, and immunotherapies. The company also engages in contract research projects and collaborates with the National Cancer Institute to advance research on cancer types such as breast cancer, glioblastoma, and lung cancer. Founded in 2005, Kiyatec aims to assist medical practitioners in identifying effective treatments for cancer patients by providing insights prior to clinical trials.
Selah Genomics
Seed Round in 2013
Selah Genomics Inc. is a clinical diagnostic specialist based in Greenville, South Carolina, that provides advanced molecular and genomic diagnostic services to healthcare providers and the pharmaceutical industry in the United States. The company focuses on enhancing diagnostic testing services, particularly in women's health, and offers specialized tests for managing chronic conditions and personalized treatment plans for cancer based on individual tumor information. Selah Genomics provides a range of services, including next-generation sequencing, RNA sequencing, targeted and exome sequencing, companion diagnostics, and bioinformatics. Founded in 2006 and formerly known as Lab21 Inc., the company aims to improve patient outcomes through its comprehensive diagnostic solutions, which support early-stage drug development, clinical trials, and regulatory processes.
CharlestonPharma
Seed Round in 2013
CharlestonPharma, LLC is dedicated to developing innovative therapeutic products aimed at cancer patients and healthcare providers. The company specializes in creating fully human monoclonal antibodies that target nucleolin, a cell surface receptor associated with various cancers. With an exclusive worldwide license from the Medical University of South Carolina for eight specific antibodies and the technology to produce additional antibodies, CharlestonPharma focuses on demonstrating the preclinical efficacy and safety of its anti-nucleolin antibodies. Laboratory studies indicate that these antibodies can selectively kill cancer cells while sparing normal cells, minimizing toxicity. Additionally, the company is working on diagnostic tests that utilize cell surface nucleolin to aid in the prognosis and diagnosis of malignant diseases. CharlestonPharma operates from the Charleston Innovation Center, where its research aims to identify the most promising antibodies for future in vivo studies. The company was incorporated in 2010 and is based in Charleston, South Carolina.
Proterra
Series B in 2012
Proterra Inc. is a manufacturer of zero-emission electric buses, primarily focused on providing sustainable transportation solutions for public and commercial transit. Founded in 2004 and headquartered in Burlingame, California, with additional offices in Greenville, South Carolina, and City of Industry, California, Proterra designs its products, including 35-foot and 40-foot electric buses, to meet the diverse needs of urban and regional transit routes. The company's Catalyst platform is noted for its modularity, allowing it to adapt to various operational demands while delivering high energy efficiency. Proterra also offers a broad range of services, including vehicle electrification solutions, fleet planning, charging infrastructure, and comprehensive vehicle maintenance programs. By facilitating the transition away from fossil fuels, Proterra aims to enhance environmental quality and reduce operational costs for fleet operators, contributing to significant reductions in greenhouse gas emissions.
RidePost
Convertible Note in 2012
RidePost, Inc. operates an online platform that connects travelers for ride-sharing and carpooling, promoting sustainability and cost-effective transportation. Founded in 2012 and based in Greenville, South Carolina, the company caters particularly to universities through its private network, RidePostU, which assists in managing transportation needs for faculty, staff, and students. By facilitating social interactions among users, RidePost enhances access to affordable travel options while allowing drivers to monetize unused seating in their vehicles. The platform aims to reduce travel costs and administrative burdens associated with traditional transportation solutions.
Zipit Wireless
Convertible Note in 2012
Zipit Wireless, Inc. is a technology company based in Greenville, South Carolina, specializing in critical messaging and Internet of Things (IoT) solutions. Founded in 2007, the company provides instant communication services designed for critical situations, catering to various sectors such as healthcare, education, government, and hospitality. Its Enterprise Critical Messaging Solution enables two-way communication for organizations, enhancing operational efficiency during emergencies. Additionally, Zipit offers cloud-based software and cellular services that support the management of connected devices, including wireless trail cameras and medication adherence devices. The company's subscription platform facilitates cellular activation and provides comprehensive business reports, allowing enterprises to streamline their operations and manage mobile workers effectively. Zipit Wireless markets its innovative software and services on a global scale, helping clients navigate the complexities of IoT connectivity.
Kiyatec
Series A in 2012
Kiyatec, LLC is a biotechnology company based in Greenville, South Carolina, specializing in the development of advanced 3D cell-based assays for preclinical drug discovery and clinical therapy applications. The company utilizes patients' own living tumor cells to create functional 3D models that facilitate testing of various cancer therapies, enhancing the predictive accuracy of drug responses. Its innovative 3DKUBE technology platform supports in situ imaging and accommodates different scaffold materials, allowing for the modeling of complex human biology through segregated cell co-culture. Kiyatec's services include drug response profiling, toxicity evaluation, and the development of cell-based models for testing small molecules, biologic drugs, and immunotherapies. The company also engages in contract research projects and collaborates with the National Cancer Institute to advance research on cancer types such as breast cancer, glioblastoma, and lung cancer. Founded in 2005, Kiyatec aims to assist medical practitioners in identifying effective treatments for cancer patients by providing insights prior to clinical trials.
Zipit Wireless
Convertible Note in 2011
Zipit Wireless, Inc. is a technology company based in Greenville, South Carolina, specializing in critical messaging and Internet of Things (IoT) solutions. Founded in 2007, the company provides instant communication services designed for critical situations, catering to various sectors such as healthcare, education, government, and hospitality. Its Enterprise Critical Messaging Solution enables two-way communication for organizations, enhancing operational efficiency during emergencies. Additionally, Zipit offers cloud-based software and cellular services that support the management of connected devices, including wireless trail cameras and medication adherence devices. The company's subscription platform facilitates cellular activation and provides comprehensive business reports, allowing enterprises to streamline their operations and manage mobile workers effectively. Zipit Wireless markets its innovative software and services on a global scale, helping clients navigate the complexities of IoT connectivity.
Proterra
Convertible Note in 2011
Proterra Inc. is a manufacturer of zero-emission electric buses, primarily focused on providing sustainable transportation solutions for public and commercial transit. Founded in 2004 and headquartered in Burlingame, California, with additional offices in Greenville, South Carolina, and City of Industry, California, Proterra designs its products, including 35-foot and 40-foot electric buses, to meet the diverse needs of urban and regional transit routes. The company's Catalyst platform is noted for its modularity, allowing it to adapt to various operational demands while delivering high energy efficiency. Proterra also offers a broad range of services, including vehicle electrification solutions, fleet planning, charging infrastructure, and comprehensive vehicle maintenance programs. By facilitating the transition away from fossil fuels, Proterra aims to enhance environmental quality and reduce operational costs for fleet operators, contributing to significant reductions in greenhouse gas emissions.
Zipit Wireless
Series A in 2010
Zipit Wireless, Inc. is a technology company based in Greenville, South Carolina, specializing in critical messaging and Internet of Things (IoT) solutions. Founded in 2007, the company provides instant communication services designed for critical situations, catering to various sectors such as healthcare, education, government, and hospitality. Its Enterprise Critical Messaging Solution enables two-way communication for organizations, enhancing operational efficiency during emergencies. Additionally, Zipit offers cloud-based software and cellular services that support the management of connected devices, including wireless trail cameras and medication adherence devices. The company's subscription platform facilitates cellular activation and provides comprehensive business reports, allowing enterprises to streamline their operations and manage mobile workers effectively. Zipit Wireless markets its innovative software and services on a global scale, helping clients navigate the complexities of IoT connectivity.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.